Kancherla Neeraj, Jeyanthi Keerthana Mani, Abbas Ramsha, Sathi Thanmay Sai Charaan Reddy, Upadhyay Amrita, Garlapati Sameer Krishna Prasad
Department of Psychiatry, King George Hospital, Visakhapatnam, Andhra Pradesh, India.
Department of Internal Medicine, Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry, India.
J Pharm Bioallied Sci. 2021 Nov;13(Suppl 2):S943-S946. doi: 10.4103/jpbs.jpbs_388_21. Epub 2021 Nov 10.
According to the latest drift in Western countries, many lawmakers are trying to formulate policy to legalize the usage of in the case of mentally vulnerable populations such as those suffering from depression, paranoia, and excessive anxiety. This particular trend has been due to short term success in the case of mood upliftment. derivatives produce effects on both mood and cognitive function, which can be a double-edged sword if not followed with proper dosage. Beneficial effects, however, are limited and studies documenting those and even more meagre. Detrimental effects, especially those suffering from various hallucinating and delusional states, have been reported extensively in the literature. Here in the review article, we have tried to study and summarize various effects of as well as -derived products in the case of people who have various mental conditions. We have also tried to consider addiction to these substances and hence develop a framework for proper utilization of in mentally ill people. Many clinicians are also in a dilemma when prescribing a -based product to treat psychotic and mood-based disorders. Hence, a better understanding of the process of -based treatment for the vulnerable population is necessary.
根据西方国家的最新趋势，许多立法者试图制定政策，使在抑郁症、偏执狂和过度焦虑等精神脆弱人群中使用[具体物质未明确]合法化。这一特殊趋势归因于在改善情绪方面取得的短期成功。[具体物质未明确]衍生物对情绪和认知功能都会产生影响，如果不遵循适当剂量，这可能是一把双刃剑。然而，其有益效果有限，记录这些效果的研究更是少之又少。文献中广泛报道了其有害影响，尤其是那些处于各种幻觉和妄想状态的人。在这篇综述文章中，我们试图研究和总结[具体物质未明确]以及[具体物质未明确]衍生产品对患有各种精神疾病的人的各种影响。我们还试图考虑对这些物质的成瘾性，从而为在精神病患者中合理使用[具体物质未明确]制定一个框架。许多临床医生在开基于[具体物质未明确]的产品来治疗精神病和情绪障碍时也陷入了两难境地。因此，有必要更好地了解针对脆弱人群的基于[具体物质未明确]的治疗过程。
